Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)
China · Delayed Price · Currency is CNY 6.28
+0.03 (0.48%)
Sep 2, 2026, 3:04 PM CST
Xiangxue Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 177.41 | 254.57 | 131.74 | 149.32 | 166.5 | 196.12 |
Short-Term Investments | - | - | 13 | - | - | 105.42 |
Trading Asset Securities | - | - | - | - | 0.13 | 65.63 |
Cash & Short-Term Investments | 177.41 | 254.57 | 144.74 | 149.32 | 166.63 | 367.17 |
Cash Growth | 84.37% | 75.88% | -3.06% | -10.39% | -54.62% | -44.58% |
Accounts Receivable | 881.21 | 798.98 | 844.23 | 794.44 | 701.7 | 1,220 |
Other Receivables | 32.81 | 31.35 | 57.53 | 52.55 | 76.47 | 346.04 |
Receivables | 914.02 | 830.33 | 901.76 | 846.99 | 778.17 | 1,566 |
Inventory | 294.74 | 295.43 | 340.92 | 411.3 | 467.07 | 761.46 |
Other Current Assets | 216.13 | 224.69 | 215.28 | 416.74 | 281.32 | 390.9 |
Total Current Assets | 1,602 | 1,605 | 1,603 | 1,824 | 1,693 | 3,086 |
Property, Plant & Equipment | 3,552 | 3,634 | 4,260 | 4,621 | 4,808 | 5,957 |
Long-Term Investments | 91.21 | 95.21 | 123.44 | 178.48 | 472.03 | 270.21 |
Goodwill | 199.72 | 199.72 | 199.72 | 199.72 | 199.72 | 266.6 |
Other Intangible Assets | 716.57 | 737.57 | 840.4 | 919.28 | 964.09 | 1,034 |
Long-Term Deferred Tax Assets | 8.97 | 9.37 | 19.66 | 28.42 | 33.35 | 19.37 |
Long-Term Deferred Charges | 278.64 | 262.34 | 248.82 | 476.81 | 440.65 | 429.51 |
Other Long-Term Assets | 202.83 | 201.44 | 203.74 | 33.08 | 30.95 | 318 |
Total Assets | 6,652 | 6,745 | 7,498 | 8,281 | 8,642 | 11,381 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 1,156 | 1,185 | 1,154 | 1,087 | 988.95 | 1,123 |
Accrued Expenses | 74.55 | 400.46 | 228.41 | 116.84 | 112.39 | 72.82 |
Short-Term Debt | 854.92 | 882.6 | 1,355 | 1,498 | 1,926 | 2,466 |
Current Portion of Long-Term Debt | 556 | 115.93 | 282.98 | 340.33 | 76.73 | 447.6 |
Current Portion of Leases | - | 3.75 | 3.35 | 3.63 | 3.25 | 2.9 |
Current Income Taxes Payable | 131.46 | 39.61 | 21.73 | 15.16 | 8.14 | 9.1 |
Current Unearned Revenue | 81.24 | 132.97 | 152.94 | 162.81 | 249.79 | 117.38 |
Other Current Liabilities | 3,938 | 3,410 | 2,184 | 1,938 | 1,868 | 2,705 |
Total Current Liabilities | 6,792 | 6,171 | 5,382 | 5,162 | 5,233 | 6,944 |
Long-Term Debt | - | 437.44 | 570.64 | 556 | 426.93 | 528.92 |
Long-Term Leases | 26.24 | 27.12 | 30.88 | 34.92 | 24.92 | 2.36 |
Long-Term Unearned Revenue | 52.14 | 50.89 | 53.18 | 60.42 | 60.35 | 65.65 |
Long-Term Deferred Tax Liabilities | 6.09 | 6.61 | 8.12 | 9.46 | 6.62 | 3.73 |
Other Long-Term Liabilities | 12.59 | 8.16 | 14.74 | 144.92 | 170.06 | 77.86 |
Total Liabilities | 6,889 | 6,701 | 6,060 | 5,967 | 5,922 | 7,623 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 661.28 | 661.28 | 661.28 | 661.28 | 661.28 | 661.36 |
Additional Paid-In Capital | 2,152 | 2,152 | 2,152 | 2,152 | 2,152 | 2,152 |
Retained Earnings | -3,392 | -3,123 | -1,731 | -882.06 | -493.1 | 138.42 |
Treasury Stock | -8.5 | -8.5 | -8.5 | -8.5 | -8.5 | -8.77 |
Comprehensive Income & Other | -41.83 | -42.34 | -19.28 | 1.69 | -5.19 | 2.07 |
Total Common Equity | -628.64 | -360.32 | 1,055 | 1,925 | 2,307 | 2,946 |
Minority Interest | 391.4 | 404.27 | 383.93 | 388.52 | 413.22 | 812.23 |
Shareholders' Equity | -237.24 | 43.95 | 1,439 | 2,313 | 2,720 | 3,758 |
Total Liabilities & Equity | 6,652 | 6,745 | 7,498 | 8,281 | 8,642 | 11,381 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,437 | 1,467 | 2,243 | 2,433 | 2,458 | 3,448 |
Net Cash (Debt) | -1,260 | -1,212 | -2,098 | -2,284 | -2,291 | -3,081 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.93 | -1.84 | -3.18 | -3.46 | -3.46 | -4.65 |
Filing Date Shares Outstanding | 655.79 | 665.18 | 661.74 | 645.14 | 659.23 | 958.52 |
Total Common Shares Outstanding | 655.79 | 665.18 | 661.74 | 645.14 | 659.23 | 958.52 |
Working Capital | -5,190 | -4,566 | -3,779 | -3,337 | -3,540 | -3,858 |
Book Value Per Share | -0.96 | -0.54 | 1.59 | 2.98 | 3.50 | 3.07 |
Tangible Book Value | -1,545 | -1,298 | 14.78 | 805.7 | 1,143 | 1,645 |
Tangible Book Value Per Share | -2.36 | -1.95 | 0.02 | 1.25 | 1.73 | 1.72 |
Buildings | - | 3,490 | 3,864 | 3,442 | 3,495 | 3,709 |
Machinery | - | 991.33 | 990.74 | 1,043 | 1,040 | 946.22 |
Construction In Progress | - | 503.79 | 614.63 | 1,214 | 1,180 | 2,106 |